Nivolumab and Pomalidomide in Treating Patients With Relapsed or Refractory Central Nervous System Diffuse Large B Cell Lymphoma or Primary Vitreoretinal Diffuse Large B Cell Lymphoma

Name: Nivolumab and Pomalidomide in Treating Patients With Relapsed or Refractory Central Nervous System Diffuse Large B Cell Lymphoma or Primary Vitreoretinal Diffuse Large B Cell Lymphoma
License: Public Domain

Mayo Clinic

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

recurrent nervous system lymphoma, recurrent primary vitreoretinal dlbcl, refractory nervous system lymphoma, refractory primary vitreoretinal dlbcl

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 474775
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.